Live feed
Filing
SC 13D
SC 13D0001213900-17-001320·ORAMED PHARMACEUTICALS INC.
Schedule 13D ownership disclosure
Oramed Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 68403P203
Event date: 2016-08-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-17-001320
- Form type
- SC 13D
- Filer
- ORAMED PHARMACEUTICALS INC.
- CIK
- CIK 1176309
- Filed
- Feb 14, 2017
- Reporting period
- Aug 30, 2016
- Description
- Schedule 13D beneficial ownership